glp-1 obesity cardiovascular news Identifying High-Risk Obese Individuals Without Diabetes for GLP-1RA Therapy Using Coronary CTA GLP-1 receptor agonists improve cardiovascular

Tier 1 generic placement is described as rare for this drug class

Glucose-6-phosphate dehydrogenase (G6PD) deficiency increases the vulnerability of erythrocytes to oxidative stress

TRICARE Prime and Select cover Wegovy and Zepbound with prior authorization Active duty service members typically have the lowest out-of-pocket medication costs TRICARE for Life no longer covers weight loss medications, effective August 31, 2025 Prior authorization requires BMI criteria, documentation, and previous weight loss attempts Wegovy is covered for weight loss

Monitoring: Watch for nausea, facial flushing and blood-pressure changes, and have a dermatologist check any pigment or mole changes during Melanotan II use